Myocardial contrast echocardiography in the assessment of patients with chronic coronary artery disease

被引:1
|
作者
de Isla, LP [1 ]
Serra, V [1 ]
Rodrigo, JL [1 ]
Almería, C [1 ]
Aubele, A [1 ]
Zamorano, JL [1 ]
机构
[1] Hosp Clin San Carlos, Inst Cardiovasc, Lab Ecocardiog, Madrid 28040, Spain
关键词
contrast echocardiography; myocardial perfusion; echo contrast agents;
D O I
10.1046/j.1540-8175.20.s1.5.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of new contrast agents and new imaging methods has lead to an emerging field of applications for myocardial contrast echocardiography (MCE) in patients suffering from chronic ischemic heart disease. Echo contrast allows the assessment of myocardial perfusion (MP) by imaging the coronary microcirculation. Several echocardiographic modalities are available, the main difference between them being the acoustic power needed to perform the study. MP is evaluated by assessing the changes in myocardial videointensity that occur after intravenous contrast injection. Evaluation of these patients is performed by using different techniques. Evaluation of coronary stenosis may be performed by using stress tests or without its use. Coronary artery stenosis >50% of the coronary luminal diameter reveals a decreased hyperemic response when myocardial oxygen demand is increased. Different methods to evaluate the presence of relevant coronary stenosis have been developed: evaluation of myocardial blood flow reserve, evaluation of myocardial blood volume, and evaluation of the transmural distribution of myocardial blood flow. The combination of wall motion analysis with MCE assessment has been demonstrated to achieve the best balance between sensitivity (86%) and specificity (88%), with the highest accuracy (86%). Without the need of any stress, the ratio systolic/diastolic myocardial blood volume has been described to increase with the presence of a epicardial coronary stenosis and it may be measured by MCE. Myocardial viability is also one of the potentials of MCE. Microvascular integrity, demonstrated by MCE, is an indicator of preserved viability and predicts functional recovery that has been validated in the setting of chronic left ventricular dysfunction secondary to chronic coronary artery disease and in the setting of post acute myocardial infarction left ventricular dysfunction. In conclusion: contrast echocardiography provides an interesting tool that offers the potential of a complete evaluation of patients with chronic coronary artery disease. This includes both diagnostic and prognostic evaluation.
引用
收藏
页码:S31 / S42
页数:12
相关论文
共 50 条
  • [21] Quantitative myocardial contrast echocardiography demonstrates decreased myocardial blood flow in ischemic coronary artery disease patients
    Murthy, TH
    Li, P
    Kuersten, B
    Stewart, S
    Locricchio, E
    Vannan, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 417A - 417A
  • [22] Part II: Recent advances in myocardial contrast echocardiography - Clinical experience in the detection of coronary artery disease with myocardial contrast echocardiography
    Porter, TR
    Xie, F
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2002, 19 (05): : 399 - 407
  • [23] Assessment of Coronary Microcirculation with Myocardial Contrast Echocardiography
    Danijela, Trifunovic
    Jelena, Dudic
    Olga, Petrovic
    Zorana, Vasiljevic-Pokrajcic
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (25) : 2943 - 2949
  • [24] Dipyridamole myocardial contrast echocardiography for detection and assessment of the extent of coronary artery disease: Comparison with MIBI SPECT and coronary angiography
    Jucquois, I
    Mathieu, I
    D'Hondt, AM
    Melin, JA
    Vanoverschelde, JLJ
    CIRCULATION, 1998, 98 (17) : 569 - 569
  • [25] Value of combined dobutamine stress echocardiography and myocardial contrast echocardiography in detecting coronary artery disease
    Aggeli, C.
    Misovoulos, P.
    Soulis, D.
    Kokkinakis, C.
    Roussakis, G.
    Christoforatou, E.
    Brili, S.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2005, 26 : 307 - 307
  • [27] Can myocardial contrast echocardiography replace SPECT for the diagnosis of coronary artery disease?
    Hickman, M
    Jeetley, P
    Sabharwal, NK
    Lahiri, A
    Senior, R
    CIRCULATION, 2003, 108 (17) : 340 - 340
  • [28] Usefulness of dobutamine stress myocardial contrast echocardiography for assessing coronary artery disease
    GUO Shizun SHU Xianhong PAN Cuizhen LI Yanlin GE Junbo and CHEN Haozhu Institute of Cardiovascular Diseases Zhongshan Hospital FudanUniversity Shanghai China Guo SZ Shu XH Pan CZLi YL Ge JB and Chen HZ
    ChineseMedicalJournal, 2005, (21) : 1766 - 1772
  • [29] Prognostic value of combined dobutamine stress echocardiography and myocardial contrast echocardiography in patients with known or suspected coronary artery disease
    Aggeli, C.
    Kokkinakis, C.
    Roussakis, G.
    Christoforatou, E.
    Giannopoulos, G.
    Brili, S.
    Barbetseas, J.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2006, 27 : 61 - 62
  • [30] Usefulness of dobutamine stress myocardial contrast echocardiography for assessing coronary artery disease
    Guo, SZ
    Shu, XH
    Pan, CZ
    Li, YL
    Ge, JB
    Chen, HZ
    CHINESE MEDICAL JOURNAL, 2005, 118 (21) : 1766 - 1772